biotechnology 1 post

• Best selling and fastest growing drugs in the 2nd quarter of 2020
  10 August 2020  ·  biotechnology pharma Healthcare
  Once more Humira® from AbbVie is the best selling drug of the quarter ($4,837M) despite headwinds in Europe from biosimilars Amgevita®, Amsparity®, Halimatoz®, Hefiya®, Hulio®, Hyrimoz®, Idacio® and Imraldi®. In the US Humira® will in 2023 lose market exclusivity to the biosimilars Amjevita®, Cyltez